Characterizing protein function and protective antibody levels to the leading P. vivax malaria vaccine candidate MSP3

Chief Investigator: Dr Danny Wilson Funding Amount: $74,662 Recipient: University of Adelaide Overview: P. vivax causes ~80 million malaria cases annually, with children in Australia’s neighbouring countries badly affected. In